In this study, we treated phylogenetically diverse Mycobacterium tuberculosis clinical strains to 65 unique drug combinations in two different host-like in vitro conditions. We observed a broad range
Mtb isolates of different lineages were selected to include both wild-type and drug-resistant strains. The aim of the study was to determine the minimum inhibitory concentrations (MICs) for Mtb of mer
